Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis. 1976

J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob

Twenty patients with multiple sclerosis, in whom treatment with azathioprine and steroids had not altered the progression of the disease, were given additional treatment with either antilymphocyte globulin (ALG) (seven patients), thoracic duct drainage (TDD) (five patients) or a combination of both (eight patients). Four of the seven patients treated with the addition of ALG showed remarkable improvement which has lasted little improvement. In the eight patients receiving both had severe allergic reactions to ALG which prevented adequate dosage. TDD alone was performed in patients sensitive to ALG. These five patients showed little improvement. In the eight patients receiving both ALG and TDD there was marked improvement in four patients which has again lasted several years. The main side effect of ALG therapy is allergic reactions. Major infections or tumour formation did not occur in any patients.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic
D013897 Thoracic Duct The largest lymphatic vessel that passes through the chest and drains into the SUBCLAVIAN VEIN. Cisterna Chyli,Chyli, Cisterna,Chylus, Cisterna,Cisterna Chylus,Duct, Thoracic,Ducts, Thoracic,Thoracic Ducts

Related Publications

J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
January 1978, Postepy higieny i medycyny doswiadczalnej,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
October 1976, Journal of the neurological sciences,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
September 1977, MMW, Munchener medizinische Wochenschrift,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
September 1979, Bollettino dell'Istituto sieroterapico milanese,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
January 1997, Terapevticheskii arkhiv,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
January 1988, Medicina,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
January 1976, Postgraduate medical journal,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
January 1976, Postgraduate medical journal,
J Ring, and J Seifert, and H Anstwurm, and E Frick, and J Mertin, and B Brass, and H Backmund, and G Lob
July 1996, Arthritis and rheumatism,
Copied contents to your clipboard!